WAYNE, PA—July 18, 2011--Bracket and Arrowhead Electronic Healthcare are excited to announce that on Friday, July 8, 2011, Bracket completed the acquisition of Arrowhead, a global provider of electronic Patient-Reported Outcome (ePRO) technologies. Bracket is United BioSource Corporation's pre-approval specialty services division serving pharmaceutical, biotech and medical device sponsors, as well as contract research organizations (CROs) worldwide.

Bracket is committed to leveraging the integration of science, technology and operational excellence to provide sponsors with unique, effective solutions that allow them to achieve greater precision and accurate outcomes in their clinical trials. The suite of ePRO solutions provided by Arrowhead will be integrated into Bracket's existing portfolio of eClinical tools, including IVRS, IWRS, and eLearning platforms thereby creating a robust, mature ePRO platform to simplify the planning, management, and data quality processes for global clinical trials with complex data collection needs.

"By joining Bracket, we will be able to increase our global operations capability with a proven leader in the specialty clinical trials industry," said Jeff Albrecht, Founder and President of Arrowhead. Arrowhead's ePRO solutions are uniquely engineered to optimally capture the patient experience in both pre- and post-approval clinical studies so trial sponsors can focus on making more accurate, efficient, and effective drug development decisions.

"Successful ePRO solutions require the sophisticated integration of science, technology and timely delivery of devices and Internet-based software worldwide—requirements which leverage Bracket's expertise and can readily benefit from UBC's outcomes research and post-marketing expertise," commented Cathe Spear, division head for Bracket.

For further information on Bracket, please visit www.BracketGlobal.com.